Fat-Soluble Statins May Alter Liver Ca Risk in Chronic Hepatitis Fat-Soluble Statins May Alter Liver Ca Risk in Chronic Hepatitis
Data from a nationwide population with confirmed viral hepatitis suggest that fat-soluble statins may exert unique, class-specific hepatoprotective effects.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Cardiology News Source Type: news
More News: Cancer & Oncology | Cardiology | Cholesterol | Heart | Hematology | Hepatitis | Liver | Statin Therapy | Urology & Nephrology